Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Strategies for Carbapenem-Resistant Acinetobacter Baumannii Infections: Study Protocol

NCT06440304 is registered in ClinicalTrials.gov with Clinical Hospital Centre Zagreb as lead sponsor.

NCT NCT06440304
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06440304 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Strategies for Carbapenem-Resistant Acinetobacter Baumannii Infections: Study Protocol
Lead sponsor
Clinical Hospital Centre Zagreb
Phase
Phase 4
Overall status
Recruiting
Start date
January 30, 2025
Completion date
February 28, 2027
Enrollment
108 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infections, bacterial, sepsis bacterial